Vitamin D Is Required for IFN-γ–Mediated Antimicrobial Activity of Human Macrophages
暂无分享,去创建一个
G. Cheng | B. Hollis | B. Bloom | D. Shin | J. Adams | M. Hewison | M. Fabri | A. Steinmeyer | S. Iyer | Dennis J. Montoya | R. Modlin | H. Bruns | S. Stenger | D. Lewinsohn | P. Sieling | S. Krutzik | Hyemi Lee | Susan Realegeno | M. Schenk | Philip T Liu | U. Zügel | J. Yuk | E. Jo | Rosane M. B. Teles
[1] J. Casanova,et al. Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease , 2011, Nature Immunology.
[2] R. Wilkinson,et al. High-dose vitamin D3 during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial , 2011, The Lancet.
[3] J. Adams,et al. T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism , 2010, Proceedings of the National Academy of Sciences.
[4] J. Parsonnet,et al. Vitamin D Deficiency and Tuberculosis Progression , 2010, Emerging infectious diseases.
[5] Sarman Singh,et al. Genome-wide Analysis of the Host Intracellular Network that Regulates Survival of Mycobacterium tuberculosis , 2010, Cell.
[6] J. Son,et al. Nitric Oxide Synthesis is Modulated by 1,25-Dihydroxyvitamin D3 and Interferon-γ in Human Macrophages after Mycobacterial Infection , 2009, Immune network.
[7] S. Anderson,et al. Association between Gc genotype and susceptibility to TB is dependent on vitamin D status , 2009, European Respiratory Journal.
[8] D. Shin,et al. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. , 2009, Cell host & microbe.
[9] M. Pypaert,et al. Targeting of the GTPase Irgm1 to the phagosomal membrane via PtdIns(3,4)P2 and PtdIns(3,4,5)P3 promotes immunity to mycobacteria , 2009, Nature Immunology.
[10] G. Cheng,et al. Convergence of IL-1β and VDR Activation Pathways in Human TLR2/1-Induced Antimicrobial Responses , 2009, PloS one.
[11] T. Ziegler,et al. Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials. , 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[12] K. Leder,et al. The profile of health problems in African immigrants attending an infectious disease unit in Melbourne, Australia. , 2009, The American journal of tropical medicine and hygiene.
[13] J. Adams,et al. IL-15 Links TLR2/1-Induced Macrophage Differentiation to the Vitamin D-Dependent Antimicrobial Pathway , 2008, The Journal of Immunology.
[14] Roberta B Carey,et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. , 2007, JAMA.
[15] R. Modlin,et al. Cutting Edge: Vitamin D-Mediated Human Antimicrobial Activity against Mycobacterium tuberculosis Is Dependent on the Induction of Cathelicidin1 , 2007, The Journal of Immunology.
[16] Peter J. Peters,et al. M. tuberculosis and M. leprae Translocate from the Phagolysosome to the Cytosol in Myeloid Cells , 2007, Cell.
[17] S. Alonso,et al. Lysosomal killing of Mycobacterium mediated by ubiquitin-derived peptides is enhanced by autophagy , 2007, Proceedings of the National Academy of Sciences.
[18] M. Lipinski,et al. Autophagy Limits Listeria monocytogenes Intracellular Growth in the Early Phase of Primary Infection , 2007, Autophagy.
[19] V. Deretic,et al. Human IRGM Induces Autophagy to Eliminate Intracellular Mycobacteria , 2006, Science.
[20] J. Adams,et al. Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response , 2006, Science.
[21] H. Koeffler,et al. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up‐regulated in myeloid cells by 1,25‐dihydroxyvitamin D3 , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[22] T. Graeber,et al. TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells , 2005, Nature Medicine.
[23] R. Wilkinson,et al. Prevalence and associations of vitamin D deficiency in foreign-born persons with tuberculosis in London. , 2005, The Journal of infection.
[24] Hiroshi Sagara,et al. Escape of Intracellular Shigella from Autophagy , 2005, Science.
[25] V. Deretic,et al. Autophagy Is a Defense Mechanism Inhibiting BCG and Mycobacterium tuberculosis Survival in Infected Macrophages , 2004, Cell.
[26] S. Hamada,et al. Autophagy Defends Cells Against Invading Group A Streptococcus , 2004, Science.
[27] S. Fortune,et al. Mycobacterium tuberculosis Inhibits Macrophage Responses to IFN-γ through Myeloid Differentiation Factor 88-Dependent and -Independent Mechanisms1 , 2004, The Journal of Immunology.
[28] P. Nibbering,et al. Expression of β‐defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells , 2002 .
[29] M. Cogswell,et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. , 2002, The American journal of clinical nutrition.
[30] S. Akira,et al. [Induction of direct antimicrobial activity through mammalian toll-like receptors]. , 2001, Pneumologie.
[31] Takeshi Noda,et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing , 2000, The EMBO journal.
[32] B. Britigan,et al. Gallium Disrupts Iron Metabolism of Mycobacteria Residing within Human Macrophages , 2000, Infection and Immunity.
[33] C. Carlberg,et al. Antagonistic Action of a 25-Carboxylic Ester Analogue of 1α,25-Dihydroxyvitamin D3 Is Mediated by a Lack of Ligand-induced Vitamin D Receptor Interaction with Coactivators* , 2000, The Journal of Biological Chemistry.
[34] R. Wilkinson,et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study , 2000, The Lancet.
[35] L. Ting,et al. Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1. , 1999, Journal of immunology.
[36] B. Bloom,et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. , 1999, Science.
[37] M. Zucca,et al. Human monocytes constitutively express membrane-bound, biologically active, and interferon-gamma-upregulated interleukin-15. , 1999, Blood.
[38] S. Dorman,et al. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection , 1999, Nature Genetics.
[39] H. Kraemer,et al. Ethnic variation in cardiovascular disease risk factors among children and young adults: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. , 1999, JAMA.
[40] T. Ganz,et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. , 1998, Science.
[41] B. Dawson-Hughes,et al. Seasonal changes in plasma 25-hydroxyvitamin D concentrations of young American black and white women. , 1998, The American journal of clinical nutrition.
[42] F. Deist,et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. , 1998, Science.
[43] J. Ho,et al. Induction of in vitro human macrophage anti-Mycobacterium tuberculosis activity: requirement for IFN-gamma and primed lymphocytes. , 1998, Journal of immunology.
[44] J. Ellner,et al. Lymphocyte-dependent inhibition of growth of virulent Mycobacterium tuberculosis H37Rv within human monocytes: requirement for CD4+ T cells in purified protein derivative-positive, but not in purified protein derivative-negative subjects. , 1998, Journal of immunology.
[45] M. Newport,et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. , 1996, The New England journal of medicine.
[46] F. Leutmezer,et al. Modulation of IgA, IgE, and IgG Fc receptor expression on human mononuclear phagocytes by 1α,25‐dihydroxyvitamin D3 and cytokines , 1995, Journal of leukocyte biology.
[47] K. Tanaka,et al. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis , 1995, Infection and immunity.
[48] P. Schlesinger,et al. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. , 1994, Science.
[49] B. Bloom,et al. Pathogenesis of tuberculosis: interaction of Mycobacterium tuberculosis with macrophages , 1993, Infection and immunity.
[50] B. Bloom,et al. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages , 1992, The Journal of experimental medicine.
[51] K. Weinberg,et al. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. , 1991, Science.
[52] J. Convit,et al. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. , 1991, Science.
[53] P. Andrew,et al. Interferon gamma fails to activate human monocyte-derived macrophages to kill or inhibit the replication of a non-pathogenic mycobacterial species. , 1991, Microbial pathogenesis.
[54] M. Denis. Killing of Mycobacterium tuberculosis within human monocytes: activation by cytokines and calcitriol , 1991, Clinical and experimental immunology.
[55] B. Hollis,et al. Racial pigmentation and the cutaneous synthesis of vitamin D. , 1991, Archives of dermatology.
[56] W. Stead,et al. Racial differences in susceptibility to infection by Mycobacterium tuberculosis. , 1990, The New England journal of medicine.
[57] G. Rook,et al. The role of gamma-interferon, vitamin D3 metabolites and tumour necrosis factor in the pathogenesis of tuberculosis. , 1987, Immunology.
[58] B. Champion,et al. Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages. , 1986, Immunology.
[59] A. J. Crowle,et al. Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria , 1985, Infection and immunity.
[60] R. Brown,et al. A study of vitamin D levels in Indonesian patients with untreated pulmonary tuberculosis. , 1985, Tubercle.
[61] J. Adams,et al. Characterization of 1 alpha-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis , 1985, The Journal of experimental medicine.
[62] J. Adams,et al. INCREASED SKIN PIGMENT REDUCES THE CAPACITY OF SKIN TO SYNTHESISE VITAMIN D3 , 1982, The Lancet.
[63] P. D. Hart,et al. RESPONSE OF CULTURED MACROPHAGES TO MYCOBACTERIUM TUBERCULOSIS, WITH OBSERVATIONS ON FUSION OF LYSOSOMES WITH PHAGOSOMES , 1971, The Journal of experimental medicine.
[64] W. Loomis. Skin-Pigment Regulation of Vitamin-D Biosynthesis in Man , 1967, Science.
[65] B. Bloom,et al. Mechanism of a Reaction in Vitro Associated with Delayed-Type Hypersensitivity , 1966, Science.
[66] M. Boyde,et al. A Systematic Review of Randomized Controlled Trials , 2011 .
[67] G. Schoolnik,et al. Genome-wide expression profiling of intracellular bacteria: The interaction of Mycobacterium tuberculosis with macrophages , 2002 .
[68] Ichael,et al. A MUTATION IN THE INTERFERON- g –RECEPTOR GENE AND SUSCEPTIBILITY TO MYCOBACTERIAL INFECTION , 2000 .
[69] D. Havlir,et al. Tuberculosis in patients with human immunodeficiency virus infection. , 1999, The New England journal of medicine.
[70] G. Rook,et al. Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. , 1986, Immunology.
[71] P. Prandoni,et al. A Case-Control Study , 2022 .